China Dasheng Biotechnology Company
CDBT · OTC
12/31/2024 | 9/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2,500 | $2,049 | $897 | $820 |
| - Cash | $3 | $0 | $0 | $2 |
| + Debt | $1,099 | $1,201 | $1,279 | $1,287 |
| Enterprise Value | $3,596 | $3,249 | $2,176 | $2,105 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$15 | -$7 | $0 | -$7 |
| % Margin | – | – | – | – |
| EBITDA | -$59 | -$34 | -$102 | -$66 |
| % Margin | – | – | – | – |
| Net Income | -$74 | -$41 | -$107 | -$134 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.001 | -0.003 | -0.003 |
| % Growth | -80% | 61.5% | 21.2% | – |
| Operating Cash Flow | -$58 | – | -$29 | -$92 |
| Capital Expenditures | -$0 | – | $0 | -$0 |
| Free Cash Flow | -$58 | – | -$29 | -$92 |